A detailed history of Aviva PLC transactions in Johnson & Johnson stock. As of the latest transaction made, Aviva PLC holds 1,529,233 shares of JNJ stock, worth $237 Million. This represents 0.67% of its overall portfolio holdings.

Number of Shares
1,529,233
Previous 1,493,496 2.39%
Holding current value
$237 Million
Previous $218 Million 13.53%
% of portfolio
0.67%
Previous 0.64%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$145.48 - $167.38 $5.2 Million - $5.98 Million
35,737 Added 2.39%
1,529,233 $248 Million
Q2 2024

Aug 02, 2024

BUY
$144.38 - $157.78 $36.6 Million - $40 Million
253,797 Added 20.47%
1,493,496 $218 Million
Q1 2024

May 14, 2024

BUY
$155.22 - $162.74 $3.88 Million - $4.06 Million
24,966 Added 2.06%
1,239,699 $196 Million
Q4 2023

Feb 09, 2024

BUY
$145.6 - $158.88 $16.4 Million - $17.9 Million
112,877 Added 10.24%
1,214,733 $190 Million
Q3 2023

Nov 13, 2023

SELL
$155.75 - $174.48 $13.4 Million - $15 Million
-85,828 Reduced 7.23%
1,101,856 $172 Million
Q2 2023

Aug 10, 2023

BUY
$154.35 - $166.11 $35.7 Million - $38.4 Million
231,184 Added 24.17%
1,187,684 $197 Million
Q1 2023

May 12, 2023

SELL
$151.05 - $180.26 $4.24 Million - $5.06 Million
-28,085 Reduced 2.85%
956,500 $148 Million
Q4 2022

Feb 09, 2023

BUY
$160.2 - $179.79 $26 Million - $29.2 Million
162,472 Added 19.76%
984,585 $174 Million
Q3 2022

Nov 14, 2022

SELL
$161.33 - $179.52 $6.28 Million - $6.98 Million
-38,904 Reduced 4.52%
822,113 $134 Million
Q2 2022

Aug 04, 2022

BUY
$168.19 - $186.01 $20.7 Million - $22.8 Million
122,803 Added 16.64%
861,017 $153 Million
Q1 2022

May 13, 2022

SELL
$158.14 - $179.59 $18.9 Million - $21.4 Million
-119,430 Reduced 13.93%
738,214 $131 Million
Q4 2021

Feb 10, 2022

SELL
$155.93 - $173.01 $12.7 Million - $14.1 Million
-81,477 Reduced 8.68%
857,644 $147 Million
Q3 2021

Nov 12, 2021

SELL
$161.5 - $179.47 $11.5 Million - $12.8 Million
-71,155 Reduced 7.04%
939,121 $152 Million
Q2 2021

Aug 10, 2021

BUY
$159.48 - $171.07 $2.25 Million - $2.42 Million
14,138 Added 1.42%
1,010,276 $166 Million
Q1 2021

May 13, 2021

BUY
$153.07 - $170.48 $3.36 Million - $3.74 Million
21,920 Added 2.25%
996,138 $164 Million
Q4 2020

Feb 10, 2021

BUY
$137.11 - $157.38 $1.26 Million - $1.44 Million
9,156 Added 0.95%
974,218 $153 Million
Q3 2020

Nov 12, 2020

SELL
$140.38 - $153.83 $4.94 Million - $5.41 Million
-35,178 Reduced 3.52%
965,062 $144 Million
Q2 2020

Aug 13, 2020

SELL
$128.81 - $155.51 $5.16 Million - $6.23 Million
-40,080 Reduced 3.85%
1,000,240 $141 Million
Q1 2020

May 14, 2020

SELL
$111.14 - $153.99 $76,019 - $105,329
-684 Reduced 0.07%
1,040,320 $136 Million
Q4 2019

Feb 10, 2020

SELL
$127.5 - $146.44 $160,140 - $183,928
-1,256 Reduced 0.12%
1,041,004 $152 Million
Q3 2019

Nov 12, 2019

SELL
$126.95 - $142.14 $13 Million - $14.6 Million
-102,645 Reduced 8.97%
1,042,260 $135 Million
Q2 2019

Jul 30, 2019

SELL
$131.15 - $144.24 $4.87 Million - $5.35 Million
-37,115 Reduced 3.14%
1,144,905 $159 Million
Q1 2019

May 14, 2019

BUY
$125.72 - $139.79 $353,776 - $393,369
2,814 Added 0.24%
1,182,020 $165 Million
Q4 2018

Feb 12, 2019

SELL
$122.84 - $147.84 $38.9 Million - $46.9 Million
-316,955 Reduced 21.18%
1,179,206 $152 Million
Q3 2018

Nov 13, 2018

SELL
$121.58 - $142.88 $8.18 Million - $9.62 Million
-67,318 Reduced 4.31%
1,496,161 $207 Million
Q2 2018

Aug 01, 2018

SELL
$119.4 - $131.76 $2.44 Million - $2.69 Million
-20,446 Reduced 1.29%
1,563,479 $190 Million
Q1 2018

May 14, 2018

SELL
$125.1 - $148.14 $16.2 Million - $19.2 Million
-129,859 Reduced 7.58%
1,583,925 $203 Million
Q4 2017

Feb 13, 2018

SELL
$131.22 - $143.62 $28.4 Million - $31.1 Million
-216,383 Reduced 11.21%
1,713,784 $239 Million
Q3 2017

Nov 13, 2017

SELL
$129.47 - $135.38 $1.79 Million - $1.87 Million
-13,802 Reduced 0.71%
1,930,167 $251 Million
Q2 2017

Aug 07, 2017

BUY
N/A
1,943,969
1,943,969 $257 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $406B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Aviva PLC Portfolio

Follow Aviva PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aviva PLC, based on Form 13F filings with the SEC.

News

Stay updated on Aviva PLC with notifications on news.